Media library

Access photos, images, or videos for stories in development. If you are a member of the working press and need a resource that is not available on this website, please email your request to and we will make every effort to respond as soon as possible. Please read our terms for usage.

Key facts

updated June 2023

Chief Executive Officer:
Princeton, New Jersey
Web Address:
NYSE Listing:
Total Revenues:
$46.2 billion in 2022
R&D Investment:
$9.5 billion in 2022, which included the discovery and development of new medicines for patients
2022 Worldwide Revenues:

ELIQUIS® (apixaban), $11.8 billion

REVLIMID® (lenalidomide), $10.0 billion

OPDIVO®(nivolumab), $8.2 billion

POMALYST® / Imnovid® (pomalidomide), $3.5 billion

ORENCIA® (abatacept), $3.5 billion

SPRYCEL® (dasatinib), $2.2 billion

YERVOY® (ipilimumab), $2.1 billion

ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound), $811 million

REBLOZYL® (luspatercept-aamt), $717 million

ABECMA® (idecabtagene vicleucel), $388 million

EMPLICITI® (elotuzumab), $296 million

OPDUALAG(nivolumab and relatlimab-rmbw): $252 million

ZEPOSIA® (ozanimod), $250 million

BREYANZI® (lisocabtagene maraleucel), $182 million

ONUREG® (azacitidine tablets), $124 million

INREBIC® (fedratinib), $85 million

CAMZYOS® (mavacamten), $24 million

SOTYKTU(deucravacitinib), $8 million

Mature and other products* $1.8 billion 

*Includes products that have lost exclusivity in major markets, over-the-counter (OTC) brands and royalty revenue.

Please click on the product links to see the Full Prescribing Information for ABECMA®ABRAXANE® , BREYANZI® CAMZYOS® ELIQUIS®, EMPLICITI®, INREBIC®, ONUREG® OPDIVO®, OPDUALAG, ORENCIA®, POMALYST® , REBLOZYL®REVLIMID® SOTYKTU SPRYCEL® , YERVOY®  and  ZEPOSIA® including Boxed WARNINGS for ABECMA®ABRAXANE®BREYANZI® CAMZYOS® ELIQUIS®INREBIC®, POMALYST®, REVLIMID®, and Boxed WARNINGS for YERVOY® regarding immune-mediated adverse reaction.

Bristol Myers Squibb Corporate B-roll

Overview B-roll

This B-roll includes a collection of footage of Bristol Myers Squibb campus exteriors, corporate signage, research and development, and manufacturing facilities.

Usage Rights & Restrictions: These media assets are free for editorial broadcast, print, online and radio use. They are restricted for other purposes.

Scientific Media Resources >
Disease State Infographics >